230 related articles for article (PubMed ID: 30776954)
21. Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
Rogers Z; Pintye J; Kinuthia J; O'Malley G; Abuna F; Escudero J; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
AIDS Care; 2022 Mar; 34(3):363-370. PubMed ID: 34543077
[TBL] [Abstract][Full Text] [Related]
22. Tu'Washindi na PrEP: Working With Young Women and Service Providers to Design an Intervention for PrEP Uptake and Adherence in the Context of Gender-Based Violence.
Hartmann M; Otticha S; Agot K; Minnis AM; Montgomery ET; Roberts ST
AIDS Educ Prev; 2021 Apr; 33(2):103-119. PubMed ID: 33821679
[TBL] [Abstract][Full Text] [Related]
23. Assessing young Kenyan women's willingness to engage in a peer-delivered HIV self-testing and referral model for PrEP initiation: A qualitative formative research study.
McGowan M; Casmir E; Wairimu N; Mogere P; Jahn A; Ngure K; Ortblad KF; Roche SD
Front Public Health; 2022; 10():932948. PubMed ID: 36276357
[TBL] [Abstract][Full Text] [Related]
24. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
[TBL] [Abstract][Full Text] [Related]
25. Influences on Early Discontinuation and Persistence of Daily Oral PrEP Use Among Kenyan Adolescent Girls and Young Women: A Qualitative Evaluation From a PrEP Implementation Program.
Pintye J; O'Malley G; Kinuthia J; Abuna F; Escudero JN; Mugambi M; Awuor M; Dollah A; Dettinger JC; Kohler P; John-Stewart G; Beima-Sofie K
J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e83-e89. PubMed ID: 33273211
[TBL] [Abstract][Full Text] [Related]
26. Fostering Access to PrEP Among Adolescent Girls and Young Women Aged 16 to 24 Years at High Risk of HIV Through the DREAMS Initiative in Four Districts in Zambia.
Chipukuma J; Lindsay B; Mwango LK; Olowski P; Baumhart C; Tembo K; Olufunso AA; Bwale C; Makasa P; Muchoka M; Tembo S; Mbokile W; Panda C; Malupande S; Lubinda R; Bwembelo B; Fundulu E; Munsongo C; Watala K; Musonda B; Chituwo O; Okuku J; Mwila A; Muleya C; Patel P; Claassen CW
AIDS Educ Prev; 2023 Jul; 35():52-66. PubMed ID: 37406141
[TBL] [Abstract][Full Text] [Related]
27. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
[TBL] [Abstract][Full Text] [Related]
28. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
29. "They have this not care - don't care attitude:" A Mixed Methods Study Evaluating Community Readiness for Oral PrEP in Adolescent Girls and Young Women in a Rural Area of South Africa.
Nakasone SE; Chimbindi N; Mthiyane N; Nkosi B; Zuma T; Baisley K; Dreyer J; Pillay D; Floyd S; Birdthistle I; Seeley J; Shahmanesh M
AIDS Res Ther; 2020 Sep; 17(1):55. PubMed ID: 32894138
[TBL] [Abstract][Full Text] [Related]
30. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
Hartmann M; Nyblade L; Otticha S; Marton T; Agot K; Roberts ST
J Int AIDS Soc; 2024 Feb; 27(2):e26213. PubMed ID: 38379129
[TBL] [Abstract][Full Text] [Related]
31. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
[TBL] [Abstract][Full Text] [Related]
32. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade.
Hill LM; Maseko B; Chagomerana M; Hosseinipour MC; Bekker LG; Pettifor A; Rosenberg NE
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25502. PubMed ID: 32602649
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial.
Munthali RJ; Stangl AL; Baron D; Barré I; Harvey S; Ramskin L; Colombini M; Naicker N; Kapiga S; Delany-Moretlwe S;
AIDS Behav; 2022 Dec; 26(12):3950-3962. PubMed ID: 35776254
[TBL] [Abstract][Full Text] [Related]
34. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
35. Youth-friendly services was the magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa.
Mudzingwa EK; de Vos L; Fynn L; Atujuna M; Katz IT; Hosek S; Celum C; Daniels J; Bekker LG; Medina-Marino A
Glob Public Health; 2024 Jan; 19(1):2349918. PubMed ID: 38752416
[TBL] [Abstract][Full Text] [Related]
36. Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya.
Omollo V; Roche SD; Mogaka F; Odoyo J; Barnabee G; Bukusi EA; Katz AWK; Morton J; Johnson R; Baeten JM; Celum C; O'Malley G
Sex Reprod Health Matters; 2022 Dec; 30(1):2095707. PubMed ID: 36169648
[TBL] [Abstract][Full Text] [Related]
37. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
Irungu E; Khoza N; Velloza J
Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
[TBL] [Abstract][Full Text] [Related]
38. Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners.
Jani N; Mathur S; Kahabuka C; Makyao N; Pilgrim N
PLoS One; 2021; 16(2):e0246717. PubMed ID: 33596216
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.
Birdthistle I; Schaffnit SB; Kwaro D; Shahmanesh M; Ziraba A; Kabiru CW; Phillips-Howard P; Chimbindi N; Ondeng'e K; Gourlay A; Cowan FM; Hargreaves JR; Hensen B; Chiyaka T; Glynn JR; Floyd S
BMC Public Health; 2018 Jul; 18(1):912. PubMed ID: 30045711
[TBL] [Abstract][Full Text] [Related]
40. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
